It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
"It is important to remember that natural immunity and vaccination are not mutually exclusive," said Jeffrey Townsend, the Elihu Professor of Biostatistics at Yale School of Public Health and the study’s lead author. "Many people will have partial immunity from multiple sources, so understanding the relative durability is key to deciding when to provide a boost to your immune system."
The study found that while mRNA vaccines produce more antibodies at peak production and therefore more protection than natural infection would, the viral vector vaccines produce approximately the same amount of antibodies as natural infection at peak capacity
originally posted by: vNex92
a reply to: network dude
If you are vaxed and have four boosters or whatever and still able managed to get re infected despite all the pre cautions.
I would have serious questions with those who are pushing these boosters.
originally posted by: ColeYounger
a reply to: vNex92
COVID-19 booster shots are crucial, according to a Yale study
The medical schools, and especially Yale, are bought and paid for by big pharma. A 5 minute online search will prove that.
The Omicron BA.4 and BA.5 subvariants of SARS-CoV-2 have proven to be stealthier at evading people’s immune defences than all of their predecessors.
But recent research shows that previous infection with an older variant (such as Alpha, Beta or Delta) offers some protection against reinfection with BA.4 or BA.5, and that a prior Omicron infection is substantially more effective. That was the conclusion of a study that evaluated all of Qatar’s COVID-19 cases since the wave of BA.4 and BA.5 infections began1.
The work, which was posted on the medRxiv preprint server on 12 July and has not yet been peer reviewed, feeds into broader research on “how different immunities combine with each other”, says study co-author Laith Abu-Raddad, an infectious-disease epidemiologist at Weill Cornell Medicine-Qatar in Doha.